StimCardio

StimCardio

StimCardio is a clinical-stage medical device company developing non-invasive wearable therapeutics for atrial fibrillation (AF). Their lead product, Rhyvive, is designed to extend AF treatment beyond the hospital and into the home, targeting a significant unmet clinical need in cardiac electrophysiology.

Total raised
Undisclosed
tracked to date
Latest round
Series A
Oct 29, 2026
Known investors
2
led by John Slump's family office, Metis Medtech

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 USA Funding Report

Read the Q4 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 USA Funding Report</a>

Funding history

  1. 1
    $30 Million Series ASeries AOct 29, 2026

    Led by John Slump's family office, Metis Medtech

    Announcement ↗

Founder

Amir Soltanianzadeh
Amir Soltanianzadeh
CEO

Investors in StimCardio

Backers from this company's tracked funding rounds.

  • JJohn Slump's family office, Metis MedtechLead investorVC firm
  • CCatalyst Health VenturesVC firm

StimCardio in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile